CD274 and neoplasm: However, because the serum samples we evaluated were collected from a cohort dating back to 2000 to 2002, at a time when genomic profiling and/or tumour PDL-1 (Programmed death-ligand 1) status was not evaluated, it is conceivable that imbalances in tumour characteristics might have accounted for the observed differences between high and low risk groups.